Technology News and Research

RSS

Novel device may help restore total eye function

An international consortium of researchers is developing a new method to bring eyes back to life from deceased body donors for clinical research purposes.

18 Dec 2020

FDA approves pembrolizumab as first-line treatment for colorectal cancer

The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with certain types of advanced colorectal cancer. This is the 9th FDA approval supported by Stand Up To Cancer® (SU2C) research.

18 Dec 2020

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

The University of Ottawa has earned a total of 10 Canada Research Chairs (CRCs) covering a broad scope of subjects, from the exploration of disruptive impacts of stress on higher brain functions to the need to preserve Indigenous traditional cultural memories, and emerging computing technologies that pave the way to smart cities.

18 Dec 2020

Study reveals innovative gene therapy approach to regenerate functional new neurons

Spinal cord injury (SCI) often causes disability and seriously compromises quality of life. While decades of research have made significant progress in axonal regeneration after SCI, most of the interventions have not been translated into clinical therapies.

18 Dec 2020

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.

17 Dec 2020

Antifungal drug improves key biomarkers in the noses of patients with cystic fibrosis

A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign and the University of Iowa found.

17 Dec 2020

MFCR awards new grants to support an emerging approach to cancer therapeutics

The Mark Foundation for Cancer Research has awarded five new grants in support of an important, emerging approach to cancer therapeutics.

17 Dec 2020

New technology tested for removing, destroying hazardous chemicals from soil and groundwater

University of Rhode Island hydrogeologist Thomas Boving and colleagues at EnChem Engineering Inc. are testing a proprietary new technology for quickly removing and destroying hazardous chemical compounds from soil and groundwater.

17 Dec 2020

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Application of low-intensity pulsed ultrasound in combination with microbubbles might enhance the delivery of chemotherapy medication used for treating cancers.

17 Dec 2020

Scientists examine the virulent potential of Listeria strains in pigs

Researchers from the CEU Cardenal Herrera University (CEU UCH) of Valencia, the University of Cordoba and the Pasteur Institute of Paris, have conducted a study to determine the virulent potential of strains of the Listeria monocytogenes bacteria in pigs in Spain.

17 Dec 2020

REPROCELL launches personalized iPSC production service alongside new B2C website for “Personal iPS” customers

REPROCELL has announced that they will launch a new service to generate individual-specific induced pluripotent stem cell (iPSC) in January.

From REPROCELL 17 Dec 2020

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Mogrify today announced it had secured the assignment of the foundational intellectual property underpinning its core direct cell conversion technology.

17 Dec 2020

Why are some groups more vulnerable to COVID-19?

News-Medical speaks to Dr. Jaswinder Singh about his research surrounding why some groups are more susceptible to severe cases of COVID-19.

17 Dec 2020

Researchers explain the role of enzyme that facilitates appropriate development of mouse embryo

The body plan of an organism, crafted over millennia of evolutionary trial and error, is so exquisitely fine-tuned that even a subtle deviation can be detrimental to individual survival and reproductive success.

17 Dec 2020

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

TRIUMF, Canada's particle accelerator center, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

17 Dec 2020

FDA grants EUA for new COVID-19 viral antigen test

The U.S. Food and Drug Administration granted emergency use authorization (EUA) today for an innovative COVID-19 viral antigen test developed with support from the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Initiative.

16 Dec 2020

Innovation Partners Institute and MavenSphere launch personal engagement app for organizations

Amid rapidly rising cases of COVID-19 in Indiana, the Innovation Partners Institute (IPI) at Purdue University and MavenSphere today launched a personal engagement app designed to give organizations a simple tool to help people monitor their COVID symptoms, track test results, and connect to important support tools and resources.

16 Dec 2020

Technology News and Research

Novel device may help restore total eye function

FDA approves pembrolizumab as first-line treatment for colorectal cancer

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

Study reveals innovative gene therapy approach to regenerate functional new neurons

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Antifungal drug improves key biomarkers in the noses of patients with cystic fibrosis

MFCR awards new grants to support an emerging approach to cancer therapeutics

New technology tested for removing, destroying hazardous chemicals from soil and groundwater

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Scientists examine the virulent potential of Listeria strains in pigs

REPROCELL launches personalized iPSC production service alongside new B2C website for “Personal iPS” customers

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Why are some groups more vulnerable to COVID-19?

Researchers explain the role of enzyme that facilitates appropriate development of mouse embryo

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

FDA grants EUA for new COVID-19 viral antigen test

Innovation Partners Institute and MavenSphere launch personal engagement app for organizations

SwRI is developing machine vision tool to improve military medical training

Potency of neutralizing antibodies predicts COVID-19 severity and survival

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News